Cargando…
Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
BACKGROUND: The presence of antiphospholipid antibodies (aPLs) plays a pivotal role in the pathogenesis of antiphospholipid antibody syndrome (APS). This study aimed to examine the diagnostic value of a set of non−criteria aPLs and their relevance with APS-related criteria and extra-criteria manifes...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132625/ https://www.ncbi.nlm.nih.gov/pubmed/37122726 http://dx.doi.org/10.3389/fimmu.2023.1107510 |
_version_ | 1785031426301755392 |
---|---|
author | Li, Siting Bai, Yina Meng, Jingjing Wang, Qian Tian, Xinping Li, Mengtao Zeng, Xiaofeng Zhao, Jiuliang Hu, Chaojun |
author_facet | Li, Siting Bai, Yina Meng, Jingjing Wang, Qian Tian, Xinping Li, Mengtao Zeng, Xiaofeng Zhao, Jiuliang Hu, Chaojun |
author_sort | Li, Siting |
collection | PubMed |
description | BACKGROUND: The presence of antiphospholipid antibodies (aPLs) plays a pivotal role in the pathogenesis of antiphospholipid antibody syndrome (APS). This study aimed to examine the diagnostic value of a set of non−criteria aPLs and their relevance with APS-related criteria and extra-criteria manifestations. METHODS: From a prospectively constructed database, consecutive APS patients consisting of 114 primary APS (PAPS group), 54 with APS secondary to SLE (SAPS group), 9 seronegative APS (SNAPS), as well as 209 patients with systemic lupus erythematosus (SLE) and 88 healthy controls were included in this study. Levels of criteria aPLs, baseline information, and APS-related criteria and extra-criteria features were extracted from the database. Serum levels of non-criteria aPLs including aPC IgG/IgM, aPI IgG/IgM, aPE IgG/IgM/IgA, aPG IgG/IgM/IgA, anti-phosphatidic acid (aPA) IgG/IgM, aSM IgG/IgM, and aPS/PT IgG/IgM were analyzed with AESKULISA® ELISA Test Kits. RESULTS: The addition of aPC IgG/M, aPI IgG/M, aPE IgG/M/A, aSM IgG/M, and aPA IgG/M to aCL or aβ2GPI IgG/M could significantly increase diagnostic sensitivity and accuracy. A significant difference between PAPS or SAPS and HC was presented in all non-criteria aPLs except for aSM IgM and aPG IgA. Eight out of nine SNAPS patients were positive for at least 1 aPL. Pregnancy morbidity was associated with aSM IgM (r = 0.22) and aSM IgG (r = 0.15). Pre-eclampsia or premature birth was associated with aSM IgG (r = 0.16), aPI IgG (r = 0.22), aPC IgG (r = 0.16), and aPG IgG (r = 0.18). Stroke was associated with aPI IgG (r = 0.2). The clinical association was also observed in DVT with aPS/PT IgG (r = 0.17). Valve lesion was positively associated with aSM IgM (Fisher test p = 0.039), APS nephropathy was associated with aPC IgG (OR 3.797), and livedo reticularis was associated with aPE IgM (OR 15.391). CONCLUSION: Additional detection of non-criteria aPLs including aPC IgG/M, aPE IgG/M/A, aPI IgG/M, aSM IgG/M, and aPA IgG/M could assist in APS diagnosis. The positivity of certain aPLs was statistically associated with both criteria and extra-criteria APS clinical manifestations. |
format | Online Article Text |
id | pubmed-10132625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101326252023-04-27 Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients Li, Siting Bai, Yina Meng, Jingjing Wang, Qian Tian, Xinping Li, Mengtao Zeng, Xiaofeng Zhao, Jiuliang Hu, Chaojun Front Immunol Immunology BACKGROUND: The presence of antiphospholipid antibodies (aPLs) plays a pivotal role in the pathogenesis of antiphospholipid antibody syndrome (APS). This study aimed to examine the diagnostic value of a set of non−criteria aPLs and their relevance with APS-related criteria and extra-criteria manifestations. METHODS: From a prospectively constructed database, consecutive APS patients consisting of 114 primary APS (PAPS group), 54 with APS secondary to SLE (SAPS group), 9 seronegative APS (SNAPS), as well as 209 patients with systemic lupus erythematosus (SLE) and 88 healthy controls were included in this study. Levels of criteria aPLs, baseline information, and APS-related criteria and extra-criteria features were extracted from the database. Serum levels of non-criteria aPLs including aPC IgG/IgM, aPI IgG/IgM, aPE IgG/IgM/IgA, aPG IgG/IgM/IgA, anti-phosphatidic acid (aPA) IgG/IgM, aSM IgG/IgM, and aPS/PT IgG/IgM were analyzed with AESKULISA® ELISA Test Kits. RESULTS: The addition of aPC IgG/M, aPI IgG/M, aPE IgG/M/A, aSM IgG/M, and aPA IgG/M to aCL or aβ2GPI IgG/M could significantly increase diagnostic sensitivity and accuracy. A significant difference between PAPS or SAPS and HC was presented in all non-criteria aPLs except for aSM IgM and aPG IgA. Eight out of nine SNAPS patients were positive for at least 1 aPL. Pregnancy morbidity was associated with aSM IgM (r = 0.22) and aSM IgG (r = 0.15). Pre-eclampsia or premature birth was associated with aSM IgG (r = 0.16), aPI IgG (r = 0.22), aPC IgG (r = 0.16), and aPG IgG (r = 0.18). Stroke was associated with aPI IgG (r = 0.2). The clinical association was also observed in DVT with aPS/PT IgG (r = 0.17). Valve lesion was positively associated with aSM IgM (Fisher test p = 0.039), APS nephropathy was associated with aPC IgG (OR 3.797), and livedo reticularis was associated with aPE IgM (OR 15.391). CONCLUSION: Additional detection of non-criteria aPLs including aPC IgG/M, aPE IgG/M/A, aPI IgG/M, aSM IgG/M, and aPA IgG/M could assist in APS diagnosis. The positivity of certain aPLs was statistically associated with both criteria and extra-criteria APS clinical manifestations. Frontiers Media S.A. 2023-04-12 /pmc/articles/PMC10132625/ /pubmed/37122726 http://dx.doi.org/10.3389/fimmu.2023.1107510 Text en Copyright © 2023 Li, Bai, Meng, Wang, Tian, Li, Zeng, Zhao and Hu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Li, Siting Bai, Yina Meng, Jingjing Wang, Qian Tian, Xinping Li, Mengtao Zeng, Xiaofeng Zhao, Jiuliang Hu, Chaojun Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients |
title | Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients |
title_full | Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients |
title_fullStr | Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients |
title_full_unstemmed | Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients |
title_short | Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients |
title_sort | prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in chinese patients |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132625/ https://www.ncbi.nlm.nih.gov/pubmed/37122726 http://dx.doi.org/10.3389/fimmu.2023.1107510 |
work_keys_str_mv | AT lisiting prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT baiyina prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT mengjingjing prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT wangqian prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT tianxinping prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT limengtao prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT zengxiaofeng prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT zhaojiuliang prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients AT huchaojun prevalenceanddiagnosticvalueofnoncriteriaantiphospholipidantibodiesforantiphospholipidsyndromeinchinesepatients |